Antenatal Corticosteroids for Late-Preterm Infants: A Decision-Analytic and Economic Analysis

Table 4

Base-case cost-effectiveness analysis comparison of ACS with labor to usual care.

GA weeks	Strategy	Cost; ($)	IC; ($)	Efficacy; (Utiles)	IE; (Utiles)	C/E; ($/Utile)	ICER; ($/QALY)	Interpretation
34	No ACS	12.8 K		155.811		82.24		Dominant
	ACS	19.9 K	7.1 K	155.923	0.112	127.55	62,888.25
35	No ACS	12.6 K		155.792		80.59		Dominant
	ACS	19.8 K	7.2 K	155.904	0.112	126.76	64,425.67
36	No ACS	12.5 K		155.774		80.33		Dominant
	ACS	19.7 K	7.2 K	155.885	0.112	126.66	64,793.71

ACS: antenatal corticosteroids; GA: gestational age; IC: incremental cost; IE: incremental efficacy; QALY: quality adjusted life year.